Immudyne PR Partners with Top Amazon Seller for Shapiro MD and Future Products
July 10 2017 - 8:30AM
ImmuDyne, Inc. (OTCQB:IMMD) (“Immudyne” or the “Company”), a leader
in the development and marketing of OTC healthcare products, is
pleased to announce Immudyne PR has partnered with MH Caribbean
Management, LLC (“MHCM”). MHCM is the owner and operator of
an Amazon Store ranked as an Amazon USA top 1000 seller (as per
Marketplace Pulse).
Given the importance of Amazon and the preference of many
consumers to purchase products through Amazon Prime, partnering
with one of the largest and most successful Amazon resellers in the
world gives Immudyne PR a big competitive advantage as Shapiro MD
continues to capture market share and expands into international
markets. In addition to its global reach, Amazon has a global
fulfillment infrastructure that fits perfectly into Immudyne’s
highly scalable, direct-response business model.
“The Amazon selling platform has become essential for brands
large and small seeking to reach the global consumer,” stated
Justin Schreiber, President of Immudyne PR. “This partnership
provides immediate and lasting benefits for Shapiro MD and future
products launched by Immudyne PR. Our customer acquisition
costs have decreased, our Amazon sales doubled within the first
week, and we’ve been able to offer other features to our customers
that are typically restricted on Amazon for new brands.”
In addition to an immediate uptick in sales, Shapiro MD was also
awarded the #1 New Release by Amazon in the Hair Regrowth
Treatments category.
“We are very pleased with the sales results of the Shapiro MD
product line since its launch in mid-May,” stated Mark McLaughlin,
Chief Executive Officer of Immudyne. “We expect inventory
levels to stabilize in the next two weeks will permit us to
continue to scale both on Amazon and through our internal
media.”
About Shapiro MD™
The Shapiro MD product line is the result of 15 years of
research and development by thought-leading dermatologists Dr.
Steven Shapiro and Dr. Michael Borenstein. It is protected by
two U.S. patents and is the only product in the hair loss vertical
that contains what we believe are the 3 most powerful,
naturally-occurring dihydrotestosterone (DHT) blocking
ingredients. DHT is widely believed to be the main culprit of
balding/hair-loss. For more information on Shapiro MD or to
purchase the product, please visit www.shapiromd.com.
About lmmuDyne
lmmuDyne, Inc. (the "Company") is a health and wellness company
that develops, manufactures, and markets innovative consumer
products. Immudyne manufactures and markets a proprietary and
patent protected Yeast Beta Glucan that has been shown in thousands
of clinical studies to support and regulate the human immune
system. It has broad applications in skincare and as an
immune support supplement. Immudyne PR, a majority owned
subsidiary of ImmuDyne, Inc., is the digital marketing arm of
Immudyne and is currently focused on marketing products for thicker
and fuller hair (Shapiro MD) and a skincare line containing
Immudyne’s proprietary Yeast Beta Glucan ingredient (Inate
MD). All of lmmuDyne's intellectual property is protected by
patents and/or trade secrets. Additional information can be found
on the web at www.immudyne.com.
Forward-Looking Statements
Cautionary language regarding Forward-Looking Statements Safe
Harbor Act Disclaimer: Forward-looking statements in this release
are made pursuant to the Safe Harbor Provisions of the Private
Securities Litigation Reform Act of 1995. Certain statements in
this press release, including projections with respect to
ImmuDyne’s results of operations, may contain words such as
"anticipates," "believes," "could," "estimates," "expects,"
"intends," "may," "projects," "plans," "targets" and other similar
language and are considered forward-looking statements. These
statements are based on management's current expectations,
estimates, and forecasts. These forward-looking statements are
subject to important assumptions, risks and uncertainties, which
are difficult to predict and therefore the actual results may be
materially different from those discussed.
Contact:
ImmuDyne, Inc.
Mark McLaughlin: +1-914-714-8901